Published in Mol Ther Nucleic Acids on May 08, 2017
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
Apoptosis: a review of programmed cell death. Toxicol Pathol (2007) 17.92
Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature (1973) 15.28
Translation of the Philadelphia chromosome into therapy for CML. Blood (2008) 4.74
Trypan blue exclusion test of cell viability. Curr Protoc Immunol (2001) 3.88
The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood (1996) 3.39
Nanoparticle PEGylation for imaging and therapy. Nanomedicine (Lond) (2011) 3.33
Molecular biology of bcr-abl1-positive chronic myeloid leukemia. Blood (2008) 2.76
Selective inhibition of leukemia cell proliferation by BCR-ABL antisense oligodeoxynucleotides. Science (1991) 1.93
Silencing disease genes in the laboratory and the clinic. J Pathol (2011) 1.72
Gene silencing by gold nanoshell-mediated delivery and laser-triggered release of antisense oligonucleotide and siRNA. ACS Nano (2012) 1.30
The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics. Cancer Discov (2015) 1.15
Effective gene silencing by multilayered siRNA-coated gold nanoparticles. Small (2010) 1.13
Design of multifunctional gold nanoparticles for in vitro and in vivo gene silencing. ACS Nano (2012) 1.10
Gold nanoparticles for nucleic acid delivery. Mol Ther (2014) 1.05
Therapeutic platforms based on gold nanoparticles and their covalent conjugates with drug molecules. Adv Drug Deliv Rev (2012) 1.05
Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib. Haematologica (2014) 1.03
Gold nanoparticle mediated laser transfection for efficient siRNA mediated gene knock down. PLoS One (2013) 1.03
Gold-nanobeacons for simultaneous gene specific silencing and intracellular tracking of the silencing events. Biomaterials (2013) 1.00
Gold-nanobeacons for gene therapy: evaluation of genotoxicity, cell toxicity and proteome profiling analysis. Nanotoxicology (2013) 0.99
A review of the European LeukemiaNet recommendations for the management of CML. Ann Hematol (2015) 0.99
Drug responses of imatinib mesylate-resistant cells: synergism of imatinib with other chemotherapeutic drugs. Leukemia (2002) 0.99
Cyto and genotoxicity of gold nanoparticles in human hepatocellular carcinoma and peripheral blood mononuclear cells. Toxicol Lett (2012) 0.95
Apoptosis and autophagy have opposite roles on imatinib-induced K562 leukemia cell senescence. Cell Death Dis (2012) 0.93
Progress on RNAi-based molecular medicines. Int J Nanomedicine (2012) 0.90
Is going for cure in chronic myeloid leukemia possible and justifiable? Hematology Am Soc Hematol Educ Program (2012) 0.90
Chronic myeloid leukemia: 2016 update on diagnosis, therapy, and monitoring. Am J Hematol (2016) 0.86
Therapeutic antisense oligonucleotides against cancer: hurdling to the clinic. Front Chem (2014) 0.84
Regulation of Bcl-2 gene expression by BCR-ABL is mediated by Ras. J Mol Biol (1997) 0.81
What challenges remain in chronic myeloid leukemia research? Haematologica (2013) 0.81
An e6a2 BCR-ABL fusion transcript in a CML patient having an iliac chloroma at initial presentation. Leuk Lymphoma (2007) 0.81
Autophagy in chronic myeloid leukaemia: stem cell survival and implication in therapy. Curr Cancer Drug Targets (2013) 0.80
Biological characterization of the antiproliferative potential of Co(II) and Sn(IV) coordination compounds in human cancer cell lines: a comparative proteomic approach. Drug Metabol Drug Interact (2013) 0.80
siRNA Nanoparticles for Ultra-Long Gene Silencing In Vivo. Methods Mol Biol (2016) 0.79
Insights into the mechanisms underlying the antiproliferative potential of a Co(II) coordination compound bearing 1,10-phenanthroline-5,6-dione: DNA and protein interaction studies. J Biol Inorg Chem (2014) 0.78
Engineering a BCR-ABL-activated caspase for the selective elimination of leukemic cells. Proc Natl Acad Sci U S A (2013) 0.77
Quantification of functionalised gold nanoparticle-targeted knockdown of gene expression in HeLa cells. PLoS One (2014) 0.77
Molecular Beacon Nano-Sensors for Probing Living Cancer Cells. Trends Biotechnol (2016) 0.76
Current trends in molecular diagnostics of chronic myeloid leukemia. Leuk Lymphoma (2016) 0.76
Water soluble heterometallic potassium-dioxidovanadium(V) complexes as potential antiproliferative agents. J Inorg Biochem (2015) 0.76
Gold Nanobeacons for Tracking Gene Silencing in Zebrafish. Nanomaterials (Basel) (2017) 0.76
A Gold Nanoparticle Platform for the Delivery of Functional TGF-β1 siRNA Into Cancer Cells. J Biomed Nanotechnol (2016) 0.76
Colorimetric assessment of BCR-ABL1 transcripts in clinical samples via gold nanoprobes. Anal Bioanal Chem (2016) 0.76
Tyrosine kinase inhibitors in chronic myeloid leukaemia: which, when, for whom? Nat Rev Clin Oncol (2016) 0.75